# Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers

> **NCT00925288** · PHASE4 · COMPLETED · sponsor: **Johns Hopkins Bloomberg School of Public Health** · enrollment: 200 (actual)

## Conditions studied

- Human Papillomavirus Infection

## Interventions

- **BIOLOGICAL:** Gardasil

## Key facts

- **NCT ID:** NCT00925288
- **Lead sponsor:** Johns Hopkins Bloomberg School of Public Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2012-10-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00925288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00925288, "Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00925288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*